NKTR · Healthcare · $1.7B
Pre-market $58.97-2.60%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출은 1,000만 달러로 전 분기 1,100만 달러에서 다시 줄었고, 지난해 4분기 2,200만 달러 이후 하락 흐름이에요.”
In the company's words · 2026 2분기 earnings call